Magnit opens a dark pharmacy


MAGNIT PJSC (MGNT) Magnit opens dark pharmacy 25-Oct-2021 / 11:30 MSK Regulatory announcement aired, transmitted by EQS Group. The issuer is solely responsible for the content of this advertisement.

————————————————– ————————————————– ——————-


Krasnodar, Russia (October 25, 2021): Magnit PJSC (MOEX and LSE: MGNT; the company, Magnit), one of Russia’s leading retailers, has launched its first dark store to provide its e-pharma capabilities. The pilot store was opened in Krasnodar.

The Dark Store complies with the country’s licensing requirements and operates as a click-and-collect pharmacy. The store with a total area of ​​250 square meters houses an online order picking area, a sales area for offline sales, as well as administrative premises. Customers ordering products from the dark store have access to a wider assortment compared to physical Magnit pharmacies: approximately 8,000 prescription and over-the-counter drugs, dietary supplements, medical devices, health products and more.

The dark store will deliver online orders to around thirty Magnit pharmacies which will be connected until the end of the week. Customers can purchase the products they need through the Magnit Pharmacy website at any time and then collect the purchased products at the most convenient pick-up point or directly from the dark store. There is no minimum order amount. Orders placed before 10 p.m. can be picked up the next day. Products ordered after 10 p.m. will be available for pickup one day later.

E-Commerce    "We continue to develop the pharmacy segment of our e-commerce. We want to leverage the dark store to 
Director      offer our customers a wider range of products with a higher availability. The dark store business model 
              has already shown its efficiency in food delivery, and now we want to see how it performs in pharma. The 
»             pilot pharmacy dark store will allow us to test operational processes and gauge customer response to base 
              our future scaling decision on." 

Previously, Magnit had launched a service allowing customers to reserve medicines in the regions. To date, the service is available in the regions of Moscow, St. Petersburg, Leningrad, Murmansk, Novgorod, Pskov and Tver, as well as in the Republic of Karelia. Until the end of the year, the project will be deployed throughout the geography of the Magnit pharmacy. As a result, customers will be able to book orders in nearly 900 of the Company’s pharmacies across the country, including more than 100 outlets in Moscow and the Moscow region.

In addition, Magnit has initiated a partnership with Uteka, a marketplace for pharmaceutical products, to increase the number of customer contacts, increase brand awareness in this market segment and obtain more information on consumer behavior. For the rest of the year, Magnit plans to test other partner platforms and further expand its own service offering.

              For further information, please contact: 
              Dina Chistyak 
              Head of Investor Relations 
              [email protected] 
              Office: +7 (861) 210 9810 x 15101 
              Media Inquiries                    Twitter 
              [email protected]                    @MagnitIR 
              Note to editors 
              Public Joint Stock Company "Magnit" is one of Russia's leading retailers. Founded in 1994, the company is 
              headquartered in the southern Russian city of Krasnodar. As of June 30, 2021, Magnit operated 39 
              distribution centers and 22,344 stores (15,348 convenience, 469 supermarkets and 6,527 drogerie stores) 
              in 3,802 cities and towns throughout 7 federal regions of the Russian Federation. 
              In accordance with the reviewed IFRS 16 results for 1H 2021, Magnit had revenues of RUB 822.2 billion and 
              an EBITDA of RUB 94.4 billion. Magnit's local shares are traded on the Moscow Exchange (MOEX: MGNT) and 
              its GDRs on the London Stock Exchange (LSE: MGNT) and it has a credit rating from Standard & Poor's of 
              Forward-looking statements 
              This document contains or may contain forward-looking statements that may or may not prove accurate. For 
              example, statements regarding expected sales growth rate and/or store openings are forward-looking 
              statements. Forward-looking statements involve known and unknown risks, uncertainties and other important 
              factors that could cause actual results to differ materially from what is expressed or implied by the 
              statements. Any forward-looking statement is based on information available to Magnit as of the date of 
              the statement. All written or oral forward-looking statements attributable to Magnit are qualified by 
              this caution. Magnit does not undertake any obligation to update or revise any forward-looking statement 
              to reflect any change in circumstances. 

————————————————– ————————————————– ——————-

ISIN:           US55953Q2021 
Category Code:  MSCU 
TIDM:           MGNT 
LEI Code:       2534009KKPTVL99W2Y12 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   125075 
EQS News ID:    1243105 
End of Announcement  EQS News Service 

Image link:

(END) Dow Jones Newswires

October 25, 2021 04:30 ET (08:30 GMT)


About Author

Leave A Reply